Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Episurf Medical ABLTS:0QUT -2.42% 14-Day RSI is 23.18 as of Jul. 24, 2026. The stock has 7 warning signs investors should review. Among 868 Medical Devices & Instruments companies, Episurf Medical AB ranks better than 93.43% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
The industry rank for Episurf Medical AB's 14-Day RSI or its related term are showing as below:
LTS:0QUT's 14-Day RSI is ranked better than 93.43% of 868
companies
in the Medical Devices & Instruments industry
Industry Median: 45.09
vs LTS:0QUT: 23.18
Episurf Medical AB (LTS:0QUT) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Episurf Medical AB 14-Day RSI Related Terms
LTS:0QUT vs ABT, SYK, MDT: 14-Day RSI Comparison
For the Medical Devices subindustry, Episurf Medical AB's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Episurf Medical AB 14-Day RSI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Episurf Medical AB's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Episurf Medical AB's 14-Day RSI falls into.
Episurf Medical AB (LTS:0QUT) 14-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Episurf Medical AB (LTS:0QUT) has a 14-Day RSI of 23.18 as of Jul. 24, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Episurf Medical AB and its competitors. According to the industry distribution chart, Episurf Medical AB ranks #57 out of 868 companies in the Medical Devices & Instruments industry, placing it in the top 6.6%.
Is Episurf Medical AB's 14-Day RSI too high?
Episurf Medical AB's current 14-Day RSI is 23.18. The Medical Devices & Instruments industry median 14-Day RSI is 45.09. Episurf Medical AB's value of 23.18 is 48.6% below this industry median. Based on the distribution chart, Episurf Medical AB ranks #57 out of 868 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does Episurf Medical AB's 14-Day RSI compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Episurf Medical AB ranks #57 out of 868 companies for 14-Day RSI. This places Episurf Medical AB in the top 7% of its industry — outperforming the majority of peers. The industry median 14-Day RSI is 45.09. Episurf Medical AB's value of 23.18 is 48.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Medical Devices & Instruments company?
The median 14-Day RSI among Medical Devices & Instruments companies is 45.09, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Episurf Medical AB's current 14-Day RSI of 23.18 is 48.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Episurf Medical AB and its competitors. For the Medical Devices & Instruments industry, the median 14-Day RSI is 45.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Episurf Medical AB's current 14-Day RSI is 23.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Episurf Medical AB stock overvalued right now?
Based on GuruFocus' analysis, Episurf Medical AB (LTS:0QUT) is currently considered Modestly Overvalued. The stock's GF Value™ is kr0.05, compared to a current price of kr0.06 — trading 13% above its estimated fair value. The current 14-Day RSI is 23.18 and 48.6% below the Medical Devices & Instruments industry median of 45.09. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Episurf Medical AB (LTS:0QUT), the current 14-Day RSI is 23.18 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Episurf Medical AB is a medical device company. The company develops, manufactures, and commercializes solutions for the repair of the local cartilage damage in human joints. Its first patient-specific product portfolio, the knee portfolio, consists of the existing products Episealer Condyle Solo and Episealer Trochlea Solo, Episealer Femoral Twin, Epiguide MOS, and Epioscopy. Episealer Patellofemoral System for the treatment of osteoarthritis limited to thepatellofemoral part of the knee joint. The company is forming a new strategic business segment through the acquisition of real estate assets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0QUT has been successfully added to your 
